Trial · NCT00778817
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Progression-free Survival Rate at 6 Weeks | 6 weeks | The analysis population excludes two patients who withdrew from the study before the 6 week assessment. | percentage of participants | NUMBER |
| PRIMARY | Progression-free Survival Rate at 12 Weeks | 12 weeks | The analysis population excludes two patients who withdrew from the study before the 6 week assessment. | percentage of participants | NUMBER |
| PRIMARY | Progression-free Survival Rate at 18 Weeks | 18 weeks | The analysis population excludes two patients who withdrew from the study before the 6 week assessment. | percentage of participants | NUMBER |
| SECONDARY | Best Response Rates | Up to 6 months | percentage of participants | NUMBER | |
| SECONDARY | Response at 6 Weeks | 6 weeks | percentage of participants | NUMBER | |
| SECONDARY | Response at 12 Weeks | 12 weeks | percentage of participants | NUMBER | |
| SECONDARY | Response at 18 Weeks | 18 weeks | percentage of participants | NUMBER | |
| SECONDARY | Response at 48 Weeks | 48 weeks | percentage of participants | NUMBER | |
| SECONDARY | Number of Patients Exhibiting Decrease in Tumor Size at 6 Weeks | 6 weeks | The analysis population excludes two patients who withdrew from the study before the 6 week assessment. | participants | NUMBER |
| SECONDARY | Number of Patients Exhibiting Decrease in Tumor Size at 12 Weeks | 12 weeks | The analysis population excludes two patients who withdrew from the study before the 6 week assessment. | participants | NUMBER |
| SECONDARY | Number of Patients Exhibiting Decrease in Tumor Size at 18 Weeks | 18 weeks | The analysis population excludes two patients who withdrew from the study before the 6 week assessment. | participants | NUMBER |
| SECONDARY | Number of Patients Exhibiting Decrease in Tumor Size at 48 Weeks | 48 weeks | The analysis population excludes two patients who withdrew from the study before the 6 week assessment. | participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00778817/outcomes